21st May 2024

PHARMANOVIA PARTNERS WITH ECHO THERAPEUTICS FOR PROMOTIONAL ACTIVITIES IN AUSTRALIA

  • AGREEMENT FOR PROMOTIONAL ACTIVITIES IN AUSTRALIA FOR SELECTED PORTFOLIO

For immediate release, 20TH May, 2024

Pharmanovia, the lifecycle management company, has today announced that it has entered into an agreement that will see Echo Therapeutics conduct promotional activities in Australia for Pharmanovia’s Pain/CNS portfolio and selected products within the endocrinology  portfolio..

Current distribution and supply arrangements for Pharmanovia’s portfolio remain unchanged.

Dimitri Pimbert, Pharmanovia’s Vice President, Asia Pacific Region commented; “A critical component of our strategy is partnering with likeminded companies who share our purpose and who are as committed as us to ensuring medicines get to the patients who need them and that’s what we have with Echo Therapeutics.”

Jude D’Silva, Echo Therapeutics Managing Director added: “This is an important milestone for Echo Therapeutics, to be given the responsibility to promote these important legacy brands. The Pharmanovia pain portfolio in particular complements our growing focus on responsible education in managing various types of pain so that patients can get on with their lives, free from pain”.

“Echo Therapeutics is committed to engaging its commercial, healthcare professional and patient know-how, to ensure that Echo’s cross functional team’s expertise, is able to not only support patients and healthcare professionals, but also deliver on business and commercial objectives.”

  • For further information, please contact:
  • Alison Dyson, Director of Communications, Pharmanovia
  • 07442 256310/ communications@pharmanovia.com
  • Or The PHA Group
    pharmanovia@thephagroup.com 
  • Jude D’Silva, Managing Director, Echo Therapeutics
  • +61 1300838428
  • customerservice@echotherapeutics.net

About Pharmanovia

Pharmanovia is a global lifecycle management healthcare company. Our mission is to revitalise iconic medicines for the benefit of patients, prescribers and payors, and utilise our capabilities to launch novel therapies.

With a diverse and growing team in over 160 countries across the globe, we deliver high-quality solutions, ethically and sustainably, across our four core therapeutic areas – Oncology, Endocrinology, Neurology and Cardiovascular.

About Echo Therapeutics ANZ

Echo Therapeutics is a proudly Australian owned pharmaceutical distributor working to ‘echo’ our partners’ brands across Australia and New Zealand. Echo was born out of the recognition of the need for a higher level of service in ANZ and we strive to Partner for Success for patients, clinicians and communities.

We are specialists in distribution of pharmaceutical products and unique services predominantly for hospitals. By connecting customer insights, we aim to have a meaningful impact on patients’ lives. We do this by partnering with global and local groups to build complementary suites of products and services for the ANZ market.